世界の血漿分画製剤市場は2023 年から 2027 年までに7.20% のCAGR で成長し、2027 年に 543 億 5000 万ドルに達すると予想されます。市場の成長要因としては、高齢者人口の増加、遺伝性疾患の有病率の増加、政府のイニシアチブ、アルブミンの需要の増加、医薬品における血漿タンパク質の使用の増加、免疫グロブリンの使用の増加、自己免疫疾患の急増などがあります。市場は、高コストや厳しい規制など、特定の課題に直面するでしょう。これらの課題を克服するために、市場は、技術の進歩、健康保険の需要の高まり、治療用タンパク質薬の使用の拡大、神経学におけるプラズマ療法の採用の増加など、いくつかの重要な動向が予想されます。
世界の血漿分画製剤市場は、免疫グロブリン、血友病、Specialty、アルブミンに分類できます。2022 年には免疫グロブリンが市場でより大きなシェアを占めました。原発性免疫不全および神経学的用途での使用が増加しているため、免疫グロブリン市場は成長が見込まれますます。たとえば、医薬品および化学メーカーである Grifols, S.A. は、2022 年 6 月に B 型肝炎曝露後予防のためのヒト血漿由来の免疫グロブリンの新しい製剤である HyperHEP B を発売し、業界を押し上げました。
目次
1. Market Overview
1.1 Plasma-Derived Therapies
1.1.1 Introduction
1.2 Segments of Plasma Derived Therapies
1.2.1 Immunoglobulin
1.2.2 Hemophilia
1.2.3 Albumin
1.3 Plasma Derived Therapy Production Process
1.4 Value Chain of Plasma Derived Therapy
1.5 Advantages of Plasma Derived Therapy for Patients
2. Impact of COVID-19
2.1 Impact of COVID-19 on HealthCare Market
2.2 Impact of COVID-19 on Plasma
2.3 Impact of COVID-19 on Plasma Collection
2.4 Prevalence of COVID-19
3. Global Market Analysis
3.1 Global Plasma Derived Therapy Market by Value
3.2 Global Plasma Derived Therapy Market Forecast by Value
3.3 Global Plasma Derived Therapy Market by Segments
3.3.1 Global Immunoglobulin Plasma Derived Therapy Market by Value
3.3.2 Global Immunoglobulin Plasma Derived Therapy Market Forecast by Value
3.3.3 Global Immunoglobulin Plasma Derived Therapy Market by Segments
3.3.4 Global Immunoglobulin Plasma Derived Therapy Market Forecast by Segments
3.3.5 Global Hemophilia Plasma Derived Therapy Market by Value
3.3.6 Global Hemophilia Plasma Derived Therapy Market Forecast by Value
3.3.7 Global Hemophilia Plasma Derived Therapy Market Forecast by Segments
3.3.8 Global Hemophilia Plasma Derived Therapy Market Forecast by Segments
3.3.9 Global Specialty Plasma Derived Therapy Market by Value
3.3.10 Global Specialty Plasma Derived Therapy Market Forecast by Value
3.3.11 Global Albumin Plasma Derived Therapy Market by Value
3.3.12 Global Albumin Plasma Derived Therapy Market Forecast by Value
3.4 Global Plasma Derived Therapy Market by Region
4. Regional Market Analysis
4.1 North America
4.1.1 North America Plasma Derived Therapy Market Forecast by Value
4.1.2 North America Plasma Derived Therapy Market by Region
4.1.3 The US Plasma Derived Therapy Market Forecast by Value
4.2 Europe
4.2.1 Europe Plasma Derived Therapy Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Plasma Derived Therapy Market Forecast by Value
4.4 LAMEA
4.4.1 LAMEA Plasma Derived Therapy Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Geriatric Population
5.1.2 Increasing Prevalence of Genetic Disorders
5.1.3 Government Initiatives
5.1.4 Rising Demand for Albumin
5.1.5 Escalating Use of Plasma Proteins in Pharmaceuticals
5.1.6 Increasing Usage of Immunoglobulin
5.1.7 Suring Autoimmune Disorders
5.2 Key Trends and Developments
5.2.1 Technological Advancements
5.2.2 Rising Demand for Health Insurance
5.2.3 Escalating Use of Therapeutic Protein Drugs
5.2.4 Increasing Adoption of Plasma Therapy in Neurology
5.3 Challenges
5.3.1 High Cost
5.3.2 Stringent Regulations
6. Competitive Landscape
6.1 Global Market
6.1.1 Plasma Market Share- Key Players
6.1.2 Immunoglobulin Market Share- Key Players
6.1.3 Albumin Market Share- Key Players
6.2 The US and Europe Market
6.2.1 The US and EU Collection Centers Key Players
7. Company Profiles
7.1 CSL Limited
7.1.1 Business Overview
7.2 Grifols
7.2.1 Business Overview
7.3 Takeda Pharmaceutical Company
7.3.1 Business Overview
7.4 Octapharma AG
7.4.1 Business Overview
7.5 Kedrion
7.5.1 Business Overview
7.6 ADMA Biologics
7.6.1 Business Overview
List of Figures
Segments of Plasma Derived Therapies
Plasma Derived Therapy Production Process
Value Chain of Plasma Derived Therapy
Advantages of Plasma Derived Therapy for Patients
Volume of Plasma Collected in the US and Number of US-based Collection Centres (2016- 2020)
Rising Coronavirus Cases in the US (Feb 2020- Mar 2022)
Global Plasma Derived Therapy Market by Value (2018-2022)
Global Plasma Derived Therapy Market Forecast by Value (2023-2027)
Global Plasma Derived Therapy Market by Segments (2022)
Global Immunoglobulin Plasma Derived Therapy Market by Value (2018-2022)
Global Immunoglobulin Plasma Derived Therapy Market Forecast by Value (2023-2027)
Global Immunoglobulin Plasma Derived Therapy Market by Segments (2022)
Global Immunoglobulin Plasma Derived Therapy Market Forecast by Segments (2022-2027)
Global Hemophilia Plasma Derived Therapy Market by Value (2018-2022)
Global Hemophilia Plasma Derived Therapy Market Forecast by Value (2023-2027)
Global Hemophilia Plasma Derived Therapy Market by Segments (2022)
Global Hemophilia Plasma Derived Therapy Market Forecast by Segments (2022-2027)
Global Specialty Plasma Derived Therapy Market by Value (2018-2022)
Global Specialty Plasma Derived Therapy Market Forecast by Value (2023-2027)
Global Albumin Plasma Derived Therapy Market by Value (2018-2022)
Global Albumin Plasma Derived Therapy Market Forecast by Value (2023-2027)
Global Plasma Derived Therapy Market by Region (2022)
North America Plasma Derived Therapy Market Forecast by Value (2021-2027)
North America Plasma Derived Therapy Market by Region (2022)
The US Plasma Derived Therapy Market Forecast by Value (2021-2027)
Europe Plasma Derived Therapy Market Forecast by Value (2021-2027)
Asia Pacific Plasma Derived Therapy Market Forecast by Value (2021-2027)
LAMEA Plasma Derived Therapy Market Forecast by Value (2021-2027)
Global Geriatric Population (2016-2022)
Diagnosed Prevalence Cases of Rheumatoid Arthritis in Eight Major Markets (2019-2029)
The U.S. Health and Medical Insurance (2018-2022)
Key Players - Plasma Market Share (2022)
Key Players - Immunoglobulin Market Share (2022)
Key Players - Albumin Market Share (2022)
Key Players -The US and EU Collection Centers (2022)
